132 related articles for article (PubMed ID: 16297641)
1. A new approach to correct the QT interval for changes in heart rate using a nonparametric regression model in beagle dogs.
Watanabe H; Miyazaki H
J Pharmacol Toxicol Methods; 2006; 53(3):234-41. PubMed ID: 16297641
[TBL] [Abstract][Full Text] [Related]
2. Application of probabilistic analysis for precisely correcting the QT interval for heart rate in telemetered common marmosets.
Honda M; Komatsu R; Holzgrefe HH; Yamada Y; Isobe T; Kimura K; Itoh T; Tamaoki N; Tabo M
J Pharmacol Toxicol Methods; 2010; 61(3):264-70. PubMed ID: 20097297
[TBL] [Abstract][Full Text] [Related]
3. The heart rate-corrected QT interval of conscious beagle dogs: a formula based on analysis of covariance.
Spence S; Soper K; Hoe CM; Coleman J
Toxicol Sci; 1998 Oct; 45(2):247-58. PubMed ID: 9848132
[TBL] [Abstract][Full Text] [Related]
4. Correction of QT values to allow for increases in heart rate in conscious Beagle dogs in toxicology assessment.
Tattersall ML; Dymond M; Hammond T; Valentin JP
J Pharmacol Toxicol Methods; 2006; 53(1):11-9. PubMed ID: 15886026
[TBL] [Abstract][Full Text] [Related]
5. A method for QT correction based on beat-to-beat analysis of the QT/RR interval relationship in conscious telemetred beagle dogs.
Batey AJ; Doe CP
J Pharmacol Toxicol Methods; 2002; 48(1):11-9. PubMed ID: 12750037
[TBL] [Abstract][Full Text] [Related]
6. Magnitude of error introduced by application of heart rate correction formulas to the canine QT interval.
King A; Bailie M; Olivier NB
Ann Noninvasive Electrocardiol; 2006 Oct; 11(4):289-98. PubMed ID: 17040276
[TBL] [Abstract][Full Text] [Related]
7. Heart rate correction models to detect QT interval prolongation in novel pharmaceutical development.
Markert M; Shen R; Trautmann T; Guth B
J Pharmacol Toxicol Methods; 2011; 64(1):25-41. PubMed ID: 21635956
[TBL] [Abstract][Full Text] [Related]
8. Non-invasive telemetric electrocardiogram assessment in conscious beagle dogs.
Prior H; McMahon N; Schofield J; Valentin JP
J Pharmacol Toxicol Methods; 2009; 60(2):167-73. PubMed ID: 19539041
[TBL] [Abstract][Full Text] [Related]
9. Novel probabilistic method for precisely correcting the QT interval for heart rate in telemetered dogs and cynomolgus monkeys.
Holzgrefe HH; Cavero I; Gleason CR; Warner WA; Buchanan LV; Gill MW; Burkett DE; Durham SK
J Pharmacol Toxicol Methods; 2007; 55(2):159-75. PubMed ID: 16857392
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of QT interval using a linear model in individual cynomolgus monkeys.
Koga T; Kuwano K; Kito G; Kanefuji K
J Pharmacol Toxicol Methods; 2007; 55(3):248-53. PubMed ID: 17141531
[TBL] [Abstract][Full Text] [Related]
11. A one-step approach to the analysis of the QT interval in conscious telemetrized dogs.
Chiang AY; Holdsworth DL; Leishman DJ
J Pharmacol Toxicol Methods; 2006; 54(2):183-8. PubMed ID: 16567113
[TBL] [Abstract][Full Text] [Related]
12. Calculation of QT shift in non clinical safety pharmacology studies.
Champeroux P; Martel E; Fowler JS; Maurin A; Sola ML; Jude S; Elamrani F; Weyn AA; Laveissiere A; Lala P; Richard S
J Pharmacol Toxicol Methods; 2009; 59(2):73-85. PubMed ID: 19135537
[TBL] [Abstract][Full Text] [Related]
13. A highly sensitive canine telemetry model for detection of QT interval prolongation: studies with moxifloxacin, haloperidol and MK-499.
Chaves AA; Zingaro GJ; Yordy MA; Bustard KA; O'Sullivan S; Galijatovic-Idrizbegovic A; Schuck H; Christian DB; Hoe CM; Briscoe RJ
J Pharmacol Toxicol Methods; 2007; 56(2):103-14. PubMed ID: 17643323
[TBL] [Abstract][Full Text] [Related]
14. Bias and variance evaluation of QT interval correction methods.
Wang Y; Pan G; Balch A
J Biopharm Stat; 2008; 18(3):427-50. PubMed ID: 18470754
[TBL] [Abstract][Full Text] [Related]
15. A novel approach to data processing of the QT interval response in the conscious telemetered beagle dog.
Ollerstam A; Persson AH; Visser SA; Fredriksson JM; Forsberg T; Nilsson LB; Eklund G; Wiklund SJ; Gabrielsson J; Duker G; Al-Saffar A
J Pharmacol Toxicol Methods; 2007; 55(1):35-48. PubMed ID: 16581270
[TBL] [Abstract][Full Text] [Related]
16. A nonparametric approach to QT interval correction for heart rate.
Wang D; Cheung YB; Arezina R; Taubel J; Camm AJ
J Biopharm Stat; 2010 May; 20(3):508-22. PubMed ID: 20358433
[TBL] [Abstract][Full Text] [Related]
17. Halothane-anaesthetized, closed-chest, guinea-pig model for assessment of drug-induced QT-interval prolongation.
Sakaguchi Y; Takahara A; Nakamura Y; Akie Y; Sugiyama A
Basic Clin Pharmacol Toxicol; 2009 Jan; 104(1):43-8. PubMed ID: 18699795
[TBL] [Abstract][Full Text] [Related]
18. Differences between study-specific and subject-specific heart rate corrections of the QT interval in investigations of drug induced QTc prolongation.
Malik M; Hnatkova K; Batchvarov V
Pacing Clin Electrophysiol; 2004 Jun; 27(6 Pt 1):791-800. PubMed ID: 15189536
[TBL] [Abstract][Full Text] [Related]
19. Accurate detection of drug-induced delayed ventricular repolarization with a suitable correction formula in Langendorff guinea pig heart.
Tabo M; Komatsu R; Isobe T; Honda M; Yamada Y; Kimura K
J Toxicol Sci; 2010 Oct; 35(5):687-98. PubMed ID: 20930463
[TBL] [Abstract][Full Text] [Related]
20. QT interval correction in patients with cirrhosis.
Zambruni A; Di Micoli A; Lubisco A; Domenicali M; Trevisani F; Bernardi M
J Cardiovasc Electrophysiol; 2007 Jan; 18(1):77-82. PubMed ID: 17229304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
